History of drug pricing reform in the United States: from policy foundations to latest reforms
Sujith Ramachandran, Arman Arabshomali, John Coster · 2026
Read History of drug pricing reform in the United States: from policy foundations to latest reforms by Sujith Ramachandran, Arman Arabshomali, John Coster (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13564212.txt.
Description
Sujith Ramachandran, Arman Arabshomali, and John Coster trace seventy years of US drug pricing policy in this 2026 review. Step-by-step reforms since the 1960s have built a system that is complex and split into pieces. Each program, Medicaid, Medicare, veterans' care, and the 340B discount plan, prices drugs its own way.
The review explains the yardsticks behind the prices, from average wholesale price to average sales price. It then walks the landmark laws: a 1990 budget act, the 2003 Medicare overhaul, the 2010 Affordable Care Act, and the 2022 Inflation Reduction Act. Each law reshaped rebates, payments, and patient costs in turn. The authors show how layering fixes on old foundations produced today's maze, and why newer reforms keep bumping into its quirks.
Catalog record
| CREATOR | Sujith Ramachandran, Arman Arabshomali, John Coster |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |